
Cybin and Kernel Announce Results from Kernel Flow® Piloting of Feasibility Study Measuring Ketamine’s Effects on the Brain
Preliminary data confirm Flow’s ability to successfully measure neuro-effect of ketamine over 10 days reports Kernel.
View the latest clinical trials, studies, data, and updates.
Preliminary data confirm Flow’s ability to successfully measure neuro-effect of ketamine over 10 days reports Kernel.
ARCIM implantable pulse generator is designed to stimulate the spinal cord to restore movement and autonomic function for people with spinal cord injury and other conditions that affect mobility notes ONWARD Medical.
The novel system is being studied for its potential to enhance and accelerate recovery reports TecTraum.
STAR-D pivotal trial is being performed under the auspices of an FDA Breakthrough Device Designation and is expected to enroll up to 120 patients across 30 sites in the United States.
Vectorious Medical Technologies advises for the first time, heart failure patients can have full visibility of their hearts’ LA pressure and self-adjust their medication to stop further deterioration and avoid hospitalizations.
NSO, a division of NuVasive, is focused on the design and innovation of disruptive orthopedic solutions for complex orthopedic reconstruction and limb lengthening.